Add like
Add dislike
Add to saved papers

A Declining Trend of <i>Leishmaniasis</i> Based on Previous Data in Larstan, South of Iran 2007-2017.

INTRODUCTION:  Cutaneous Leishmaniasis is a unicellular of the Leishmania type, and 0.7 to 1.2 million people are annually infected by Cutaneous Leishmaniasis. Larestan is one of the southern cities of Fars Province. Every year, some issues of Cutaneous Leishmaniasis are reported from Larestan. This study aims to analyze the prevalence of Cutaneous Leishmaniasis in Larestan from 2007 to 2017.

METHODOLOGY: The present study is a cross-sectional descriptive-analytical study which is carried out in Larestan. The study population consists of those people who are infected by Cutaneous Leishmaniasis during 2007 to 2017 and are referred to health care centers. The methodology and data collection are done based on the recorded information.

RESULTS: Among 4,965 Cutaneous Leishmaniasis infected patients who referred to health care centers of Larestan, 2407 patients (48.47%) are males and 2558 patients (51.53%) are females. In the ten-year time period of the study, 1,315 (26.6%) were infected to Cutaneous Leishmaniasis in 2010. The maximum infected group consisted of 1,303 patients ranging from 0-5 years old, and the minimum infected group consisted of 90 patients ranging from 55-60 years old.

DISCUSSION:  This study showed that female subjects were more polluted in Larestan city. There is also a significant relationship between age and cutaneous leishmaniasis. Finally, it was found that the disease in the city of Larestan has been decreasing.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app